NASDAQ:DRTS - IL0011839383 - Common Stock
The current stock price of DRTS is 3.16 USD. In the past month the price increased by 3.27%. In the past year, price increased by 43.64%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.06 | 230.77B | ||
ISRG | INTUITIVE SURGICAL INC | 59.15 | 170.69B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.52 | 157.32B | ||
SYK | STRYKER CORP | 30.68 | 150.71B | ||
MDT | MEDTRONIC PLC | 16.76 | 118.79B | ||
BDX | BECTON DICKINSON AND CO | 13.99 | 57.23B | ||
IDXX | IDEXX LABORATORIES INC | 53.75 | 51.64B | ||
EW | EDWARDS LIFESCIENCES CORP | 31.84 | 48.04B | ||
RMD | RESMED INC | 30.76 | 43.01B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 16.14 | 34.34B | ||
DXCM | DEXCOM INC | 48.39 | 32.26B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.97 | 27.29B |
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
ALPHA TAU MEDICAL LTD
Kiryat Hamada 5
JERUSALEM IL
Employees: 125
Phone: 97235774115
The current stock price of DRTS is 3.16 USD. The price increased by 0.64% in the last trading session.
The exchange symbol of ALPHA TAU MEDICAL LTD is DRTS and it is listed on the Nasdaq exchange.
DRTS stock is listed on the Nasdaq exchange.
10 analysts have analysed DRTS and the average price target is 8.93 USD. This implies a price increase of 182.44% is expected in the next year compared to the current price of 3.16. Check the ALPHA TAU MEDICAL LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ALPHA TAU MEDICAL LTD (DRTS) has a market capitalization of 268.73M USD. This makes DRTS a Micro Cap stock.
ALPHA TAU MEDICAL LTD (DRTS) currently has 125 employees.
ALPHA TAU MEDICAL LTD (DRTS) has a support level at 3.01 and a resistance level at 3.4. Check the full technical report for a detailed analysis of DRTS support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DRTS does not pay a dividend.
ALPHA TAU MEDICAL LTD (DRTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.48).
The outstanding short interest for ALPHA TAU MEDICAL LTD (DRTS) is 0.13% of its float. Check the ownership tab for more information on the DRTS short interest.
ChartMill assigns a technical rating of 9 / 10 to DRTS. When comparing the yearly performance of all stocks, DRTS is one of the better performing stocks in the market, outperforming 83.48% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to DRTS. DRTS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months DRTS reported a non-GAAP Earnings per Share(EPS) of -0.48. The EPS decreased by -20% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -36.83% | ||
ROE | -50.67% | ||
Debt/Equity | 0.09 |
10 analysts have analysed DRTS and the average price target is 8.93 USD. This implies a price increase of 182.44% is expected in the next year compared to the current price of 3.16.